These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36006546)

  • 1. Studies on glycogen storage disease type 1a animal models: a brief perspective.
    Petrova IO; Smirnikhina SA
    Transgenic Res; 2022 Dec; 31(6):593-606. PubMed ID: 36006546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice.
    Clar J; Mutel E; Gri B; Creneguy A; Stefanutti A; Gaillard S; Ferry N; Beuf O; Mithieux G; Nguyen TH; Rajas F
    Hum Mol Genet; 2015 Apr; 24(8):2287-96. PubMed ID: 25561689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a.
    Roseman DS; Khan T; Rajas F; Jun LS; Asrani KH; Isaacs C; Farelli JD; Subramanian RR
    Mol Ther; 2018 Mar; 26(3):814-821. PubMed ID: 29428299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
    Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
    J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed lipid metabolism in glycogen storage disease type 1.
    Bandsma RH; Smit GP; Kuipers F
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S65-9. PubMed ID: 12373575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a.
    Resaz R; Cangelosi D; Morini M; Segalerba D; Mastracci L; Grillo F; Bosco MC; Bottino C; Colombo I; Eva A
    Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32620541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease.
    Rajas F; Clar J; Gautier-Stein A; Mithieux G
    J Inherit Metab Dis; 2015 May; 38(3):521-7. PubMed ID: 25164786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glycogen storage disease type 1a patient with type 2 diabetes.
    Sun Y; Qiang W; Wu R; Yin T; Yuan J; Yuan J; Gu Y
    BMC Med Genomics; 2022 Sep; 15(1):205. PubMed ID: 36167523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas.
    Mutel E; Abdul-Wahed A; Ramamonjisoa N; Stefanutti A; Houberdon I; Cavassila S; Pilleul F; Beuf O; Gautier-Stein A; Penhoat A; Mithieux G; Rajas F
    J Hepatol; 2011 Mar; 54(3):529-37. PubMed ID: 21109326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR-associated protein 9-Mediated Gene Editing.
    Rutten MGS; Derks TGJ; Huijkman NCA; Bos T; Kloosterhuis NJ; van de Kolk KCWA; Wolters JC; Koster MH; Bongiovanni L; Thomas RE; de Bruin A; van de Sluis B; Oosterveer MH
    Hepatology; 2021 Nov; 74(5):2491-2507. PubMed ID: 34157136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review.
    Cho JH; Weinstein DA; Lee YM
    J Inherit Metab Dis; 2021 Jan; 44(1):118-128. PubMed ID: 32474930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease.
    Cao J; Choi M; Guadagnin E; Soty M; Silva M; Verzieux V; Weisser E; Markel A; Zhuo J; Liang S; Yin L; Frassetto A; Graham AR; Burke K; Ketova T; Mihai C; Zalinger Z; Levy B; Besin G; Wolfrom M; Tran B; Tunkey C; Owen E; Sarkis J; Dousis A; Presnyak V; Pepin C; Zheng W; Ci L; Hard M; Miracco E; Rice L; Nguyen V; Zimmer M; Rajarajacholan U; Finn PF; Mithieux G; Rajas F; Martini PGV; Giangrande PH
    Nat Commun; 2021 May; 12(1):3090. PubMed ID: 34035281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors.
    Nakamura T; Ozawa T; Kawasaki T; Nakamura H; Sugimura H
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1402-8. PubMed ID: 11851840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
    Zhou J; Waskowicz LR; Lim A; Liao XH; Lian B; Masamune H; Refetoff S; Tran B; Koeberl DD; Yen PM
    Thyroid; 2019 Aug; 29(8):1158-1167. PubMed ID: 31337282
    [No Abstract]   [Full Text] [Related]  

  • 15. A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T.
    Ito K; Tajima G; Kamisato C; Tsumura M; Iwamoto M; Sekiguchi Y; Numata Y; Watanabe K; Yabe Y; Kanki S; Fujieda Y; Goto K; Sogawa Y; Oitate M; Nagase H; Tsuji S; Nishizawa T; Kakuta M; Masuda T; Onishi Y; Koizumi M; Nakamura H; Okada S; Matsuo M; Takaishi K
    J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37788110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: Hepatocellular carcinoma in type 1a glycogen storage disease with identification of a glucose-6-phosphatase gene mutation in one family.
    Nakamura T; Ozawa T; Kawasaki T; Yasumi K; Wang DY; Kitagawa M; Takehira Y; Tamakoshi K; Yamada M; Kida H; Sugie H; Nakamura H; Sugimura H
    J Gastroenterol Hepatol; 1999 Jun; 14(6):553-8. PubMed ID: 10385064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia.
    Waskowicz LR; Zhou J; Landau DJ; Brooks ED; Lim A; Yavarow ZA; Kudo T; Zhang H; Wu Y; Grant S; Young SP; Huat BB; Yen PM; Koeberl DD
    Hum Mol Genet; 2019 Jan; 28(1):143-154. PubMed ID: 30256948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine-Derived Epithelial Cells as a New Model to Study Renal Metabolic Phenotypes of Patients with Glycogen Storage Disease 1a.
    Lenzini L; Iori E; Scannapieco F; Carraro G; Avogaro A; Vitturi N
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of glycogen storage disease type 1a in a mouse model by gene therapy.
    Zingone A; Hiraiwa H; Pan CJ; Lin B; Chen H; Ward JM; Chou JY
    J Biol Chem; 2000 Jan; 275(2):828-32. PubMed ID: 10625614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of metabolic abnormalities in a mouse model of glycogen storage disease type Ia by CRISPR/Cas9-based gene editing.
    Arnaoutova I; Zhang L; Chen HD; Mansfield BC; Chou JY
    Mol Ther; 2021 Apr; 29(4):1602-1610. PubMed ID: 33359667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.